Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response After Vaccination Against Pandemic A/H1N1 Influenza in the Immunocompromised Host. Vaccination Response in ImmunoCompromised Host

NCT01066169 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT01066169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response After Vaccination Against Pandemic A/H1N1 Influenza in the Immunocompromised Host. Vaccination Response in ImmunoCompromised Host
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
February 28, 2010
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv